Physical Therapists in Buffalo, MO Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Tisha Pinon Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 W Cooper St, Buffalo, MO 65622 Phone: 417-345-5413 Fax: 417-345-8674 |
Ashley Justine Perkins, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 631 W Main St, Buffalo, MO 65622 Phone: 417-345-1378 |
Mrs. Nancy D Drake, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 55 Kelly Rd, Buffalo, MO 65622 Phone: 417-345-5210 Fax: 417-345-5210 |
 Mr. Gonzalo Remulla Ii Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 750 W Cooper St, Buffalo, MO 65622 Phone: 417-345-5413 Fax: 417-345-8674 |
 Horses Of Hope Missouri Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 55 Kelly Rd, Buffalo, MO 65622 Phone: 417-345-5210 Fax: 417-345-0131 |
News Archive
Covalon to showcase advanced medical coating capabilities at AUA annual meeting
Covalon Technologies Ltd., an advanced medical technologies company, today announced it will be showcasing its advanced medical coating capabilities, including its SilverCoat Antimicrobial Silicone Foley Catheter as well as its recently FDA cleared IV Clear antimicrobial silicone adhesive film dressing from May 19th to May 23rd at the American Urological Association 2012 Annual Meeting in Atlanta, Georgia.
Researchers discover protein that stimulates production of beta-amyloid
Researchers at the Fisher Center for Alzheimer's Disease Research laboratory today published "Gamma-secretase Activating Protein is a Therapeutic Target for Alzheimer's Disease" in Nature online. Drs. Gen He (lead author) and Paul Greengard have discovered a protein that stimulates the production of beta-amyloid, and therefore represents a major new advance in Alzheimer's disease research.
Rice University researcher receives 2010 Glycerine Innovation Award
Escherichia coli - E. coli for short - is often identified as a bacterium that contributes to foodborne illness. But research led by a Rice University scientist has discovered ways to use a safe, non-pathogenic E. coli to convert glycerine into high value fuels and chemicals.
Adlyfe receives award from the development of blood test for animal prion diseases
Adlyfe, Inc., a privately held biotech company headquartered in Rockville, MD, focused on early diagnostics for animal and human brain diseases announced the award today of a $650,000 two year grant from the Department of Environment, Food and Rural Affairs (DEFRA) in the UK for continued development of a sensitive early blood test for animal prion diseases.
Bayer HealthCare seeks EU marketing authorization of EYLEA for macular edema following BRVO
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that Bayer HealthCare has submitted an application to the European Medicines Agency (EMA) seeking marketing authorization in the European Union (EU) for EYLEA (aflibercept) Injection for the treatment of macular edema following branch retinal vein occlusion (BRVO).
› Verified 7 days ago
Optometrists
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Chiropractors